Advisor Group’s Rosetta Genomics Ltd. ROSG Stock Holding History

Advisor Group’s Portfolio ROSG Stock Details ROSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-57	Closed	–	–	5070
2017 Q1	$0	Buy	+57	New	+$307	﹤0.01%	4929

Other funds holding ROSG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HCM

Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Advisor Group's ROSG Position: Q2 2017 in Review

Advisor Group sold out of Rosetta Genomics Ltd. (ROSG) in Q2 2017, closing a stake of 57 shares.

Advisor Group first reported a position in ROSG in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 6 funds tracked by Wall St. Rank hold ROSG as of Q2 2017.

Advisor Group reported no remaining Rosetta Genomics Ltd. position as of Q2 2017 after selling out during the quarter.
Advisor Group sold 57 Rosetta Genomics Ltd. shares in Q2 2017.
Advisor Group first reported a position in Rosetta Genomics Ltd. in Q1 2017 and held it in 1 quarter.
Advisor Group's Rosetta Genomics Ltd. position peaked at $0 in Q1 2017.
6 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2017.

Based on Advisor Group's 13F filing for Q2 2017, filed 11 Aug 2017.